Covered recipient · General Payments record
JUDITH C BROOKS
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$948.99
- Reported across 29 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $330.74 | 12 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $112.00 | 1 |
| Amgen Inc. | $85.15 | 5 |
| Novo Nordisk AS | $67.50 | 3 |
| Exact Sciences Corporation | $27.76 | 1 |
| Abbott Laboratories | $22.90 | 1 |
| Lilly USA, LLC | $15.43 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $22.90 | 05/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124914945 | CMS |
| Amgen Inc. | $20.19 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117210564 | CMS |
| Amgen Inc. | $16.49 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117210566 | CMS |
| Amgen Inc. | $20.96 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117210572 | CMS |
| Amgen Inc. | $13.12 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117210568 | CMS |
| Amgen Inc. | $14.39 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117210570 | CMS |
| AstraZeneca Pharmaceuticals LP | $112.00 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105492449 | CMS |
| Exact Sciences Corporation | $27.76 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114599881 | CMS |
| Lilly USA, LLC | $15.43 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135088071 | CMS |
| Novo Nordisk Inc | $24.95 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096644244 | CMS |
| Novo Nordisk Inc | $17.56 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096902093 | CMS |
| Novo Nordisk Inc | $24.99 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097139806 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.